# Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

> **NCT01980979** · NA · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Remodulin

## Key facts

- **NCT ID:** NCT01980979
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2017-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980979, "Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01980979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*